NDRA (ENDRA Life Sciences Inc. Common Stock) Stock Analysis - Hedge Fund Holdings
ENDRA Life Sciences Inc. Common Stock (NDRA) is a publicly traded Healthcare sector company. As of May 21, 2026, NDRA trades at $5.55 with a market cap of $6.71M and a P/E ratio of -0.63. NDRA moved +0.00% today. Year to date, NDRA is +22.52%; over the trailing twelve months it is +79.32%. Its 52-week range spans $2.90 to $22.68. Analyst consensus is buy with an average price target of $27.00. Rallies surfaces NDRA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns NDRA stock?
Hedge funds tracked by Rallies that own NDRA include Two Sigma. The latest tracked quarter is Sep 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for ENDRA Life Sciences Inc. Common Stock.
NDRA Key Metrics
Key financial metrics for NDRA
Metric
Value
Price
$5.55
Market Cap
$6.71M
P/E Ratio
-0.63
EPS
$-8.93
Dividend Yield
0.00%
52-Week High
$22.68
52-Week Low
$2.90
Volume
16
Avg Volume
0
Revenue (TTM)
$0
Net Income
$-7.03M
Gross Margin
0.00%
Top Hedge Funds Holding NDRA
Two Sigma holds 19.21K shares of NDRA, changed -59.91% as of Sep 30, 2024.
Hedge funds tracked by Rallies that own NDRA include Two Sigma. The latest tracked quarter is Sep 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for ENDRA Life Sciences Inc. Common Stock.
Does Rallies show 13F holders for NDRA?
Yes. Rallies tracks hedge fund and 13F ownership data for NDRA, including fund names, share counts, latest tracked quarter, and position changes when available.
Is NDRA research on Rallies investment advice?
No. Rallies provides research, data, and educational context for NDRA. It does not provide personalized investment advice.